About: Clinical Potential of UTE‐MRI for Assessing COVID‐19: Patient‐ and Lesion‐Based Comparative Analysis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Clinical Potential of UTE‐MRI for Assessing COVID‐19: Patient‐ and Lesion‐Based Comparative Analysis Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Clinical Potential of UTE‐MRI for Assessing COVID‐19: Patient‐ and Lesion‐Based Comparative Analysis
Creator	Zhang, Zhiyong Lu, Hongzhou Shen, Jie Zhang, Yunfei Shi, Yuxin Ling, Yun Shan, Fei Dai, Yongming Ding, Xueting Qi, Huali Yang, Shuyi Zhang, Rengyin
Source	Medline; PMC
abstract	BACKGROUND: Chest computed tomography (CT) has shown tremendous clinical potential for screening, diagnosis, and surveillance of COVID‐19. However, safety concerns are warranted due to repeated exposure of X‐rays over a short period of time. Recent advances in MRI suggested that ultrashort echo time MRI (UTE‐MRI) was valuable for pulmonary applications. PURPOSE: To evaluate the effectiveness of UTE‐MRI for assessing COVID‐19. STUDY TYPE: Prospective. POPULATION: In all, 23 patients with COVID‐19 and with an average interval of 2.81 days between hospital admission and image examination. FIELD STRENGTH/SEQUENCE: 3T; Respiratory‐gated three‐dimensional radial UTE pulse sequence. ASSESSMENT: Image quality score. Patient‐ and lesion‐based interobserver and intermethod agreement for identifying the representative image findings of COVID‐19. STATISTICAL TESTS: Wilcoxon‐rank sum test, Kendall's coefficient of concordance (Kendall's W), intraclass coefficients (ICCs), and weighted kappa statistics. RESULTS: There was no significant difference between the image quality of CT and UTE‐MRI (CT vs. UTE‐MRI: 4.3 ± 0.4 vs. 4.0 ± 0.5, P = 0.09). Moreover, both patient‐ and lesion‐based interobserver agreement of CT and UTE‐MRI for evaluating the image signs of COVID‐19 were determined as excellent (ICC: 0.939–1.000, P < 0.05; Kendall's W: 0.894–1.000, P < 0.05.). In addition, the intermethod agreement of two image modalities for assessing the representative findings of COVID‐19 including affected lobes, total severity score, ground glass opacities (GGO), consolidation, GGO with consolidation, the number of crazy paving pattern, and linear opacities, as well as pseudocavity were all determined as substantial or excellent (kappa: 0.649–1.000, P < 0.05; ICC: 0.913–1.000, P < 0.05). DATA CONCLUSION: Pulmonary MRI with UTE is valuable for assessing the representative image findings of COVID‐19 with a high concordance to CT. EVIDENCE LEVEL: 2 TECHNICAL EFFICACY STAGE: 3
has issue date	2020-06-03(xsd:dateTime)
bibo:doi	10.1002/jmri.27208
bibo:pmid	32491257
has license	no-cc
sha1sum (hex)	a30788c94dc6decd35f050f06df7e677d70b3fca
schema:url	https://doi.org/10.1002/jmri.27208
resource representing a document's title	Clinical Potential of UTE‐MRI for Assessing COVID‐19: Patient‐ and Lesion‐Based Comparative Analysis
has PubMed Central identifier	PMC7300684
has PubMed identifier	32491257
schema:publication	J Magn Reson Imaging
resource representing a document's body	covid:a30788c94dc6decd35f050f06df7e677d70b3fca#body_text
is schema:about of	named entity 'COVID-19' named entity 'Field strength' named entity 'kappa' named entity 'COVID-19' named entity 'SUM' named entity 'SAFETY' named entity 'RANK' named entity 'EXCELLENT' named entity '4.3' named entity 'PATIENTS' named entity 'GATED' named entity '0.5' named entity 'MRI' named entity 'concordance' named entity 'admission' named entity 'Kendall' named entity 'COVID-19' named entity 'days' named entity 'interval' named entity 'pulse sequence' named entity 'hospital' named entity 'COVID-19' named entity 'image' named entity 'However' named entity 'ICCs' named entity 'image' named entity 'MRI' named entity 'MRI' named entity 'lesion' named entity 'COVID-19' named entity 'MRI' named entity '1.000' named entity 'significant difference' named entity 'COVID-19' named entity 'parenchyma' named entity 'crazy paving' named entity 'COVID-19' named entity 'Lesion' named entity 'inclusion and exclusion criteria' named entity 'MRI' named entity 'crazy paving' named entity 'GGO' named entity 'clinical characteristics' named entity 'MRI' named entity 'GGO' named entity 'RT-PCR' named entity 'MRI' named entity 'COVID-19' named entity 'MRI' named entity 'prospective study' named entity 'MRI' named entity 'GGO' named entity 'cystic fibrosis' named entity 'GGO' named entity 'sample size' named entity 'echo time' named entity 'MRI' named entity 'k-space' named entity 'anteroposterior' named entity '1.000' named entity 'MRI' named entity 'MRI' named entity 'lesion' named entity '1.000' named entity 'Japan' named entity 'GGO' named entity 'GGO' named entity 'MRI' named entity 'crazy paving' named entity 'chest CT'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software